Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer (Q37116142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

12

Richard Sainsbury

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Allan Hackshaw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michael Baum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Tommy Fornander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Bo Nordenskjold

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Antonio Nicolucci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Kathryn Monson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sharon Forsyth

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Krystyna Reczko

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ulla Johansson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Helena Fohlin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

English

0 references

publication date

24 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

341-349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole

22 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Long-term implications of bone loss in breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Early discontinuation of tamoxifen: a lesson for oncologists.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650713

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN498

Epidemiology and prevention of breast cancer

21 January 2018

1 reference

12 December 2020

Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study

1 reference

12 December 2020

Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII

1 reference

12 December 2020

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJN498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19244174%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

19244174

1 reference